Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 483

1.

Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.

Kobayashi Y, Okada Y, Itakura G, Iwai H, Nishimura S, Yasuda A, Nori S, Hikishima K, Konomi T, Fujiyoshi K, Tsuji O, Toyama Y, Yamanaka S, Nakamura M, Okano H.

PLoS One. 2012;7(12):e52787. doi: 10.1371/journal.pone.0052787. Epub 2012 Dec 27.

2.

Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets.

Yamane J, Nakamura M, Iwanami A, Sakaguchi M, Katoh H, Yamada M, Momoshima S, Miyao S, Ishii K, Tamaoki N, Nomura T, Okano HJ, Kanemura Y, Toyama Y, Okano H.

J Neurosci Res. 2010 May 15;88(7):1394-405. doi: 10.1002/jnr.22322.

PMID:
20091712
3.

Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.

Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y, Fujiyoshi K, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Yamanaka S, Nakamura M, Okano H.

Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16825-30. doi: 10.1073/pnas.1108077108. Epub 2011 Sep 26.

4.

Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.

Yasuda A, Tsuji O, Shibata S, Nori S, Takano M, Kobayashi Y, Takahashi Y, Fujiyoshi K, Hara CM, Miyawaki A, Okano HJ, Toyama Y, Nakamura M, Okano H.

Stem Cells. 2011 Dec;29(12):1983-94. doi: 10.1002/stem.767.

5.

Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury.

Nishimura S, Yasuda A, Iwai H, Takano M, Kobayashi Y, Nori S, Tsuji O, Fujiyoshi K, Ebise H, Toyama Y, Okano H, Nakamura M.

Mol Brain. 2013 Jan 8;6:3. doi: 10.1186/1756-6606-6-3.

6.

Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.

Itakura G, Kobayashi Y, Nishimura S, Iwai H, Takano M, Iwanami A, Toyama Y, Okano H, Nakamura M.

PLoS One. 2015 Feb 23;10(2):e0116413. doi: 10.1371/journal.pone.0116413. eCollection 2015.

7.

Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.

Iwai H, Nori S, Nishimura S, Yasuda A, Takano M, Tsuji O, Fujiyoshi K, Toyama Y, Okano H, Nakamura M.

Cell Transplant. 2014;23(11):1451-64. doi: 10.3727/096368913X670967. Epub 2013 Aug 30.

PMID:
23998989
8.

Efficient derivation of multipotent neural stem/progenitor cells from non-human primate embryonic stem cells.

Shimada H, Okada Y, Ibata K, Ebise H, Ota S, Tomioka I, Nomura T, Maeda T, Kohda K, Yuzaki M, Sasaki E, Nakamura M, Okano H.

PLoS One. 2012;7(11):e49469. doi: 10.1371/journal.pone.0049469. Epub 2012 Nov 14.

9.

Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.

Iwai H, Shimada H, Nishimura S, Kobayashi Y, Itakura G, Hori K, Hikishima K, Ebise H, Negishi N, Shibata S, Habu S, Toyama Y, Nakamura M, Okano H.

Stem Cells Transl Med. 2015 Jul;4(7):708-19. doi: 10.5966/sctm.2014-0215. Epub 2015 May 27.

10.

Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.

Okubo T, Iwanami A, Kohyama J, Itakura G, Kawabata S, Nishiyama Y, Sugai K, Ozaki M, Iida T, Matsubayashi K, Matsumoto M, Nakamura M, Okano H.

Stem Cell Reports. 2016 Oct 11;7(4):649-663. doi: 10.1016/j.stemcr.2016.08.015. Epub 2016 Sep 22.

11.

[Therapeutic potential of induced pluripotent stem cells for spinal cord injury].

Nori S, Tsuji O, Okada Y, Toyama Y, Okano H, Nakamura M.

Brain Nerve. 2012 Jan;64(1):17-27. Review. Japanese.

PMID:
22223498
12.

Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model.

Nutt SE, Chang EA, Suhr ST, Schlosser LO, Mondello SE, Moritz CT, Cibelli JB, Horner PJ.

Exp Neurol. 2013 Oct;248:491-503. doi: 10.1016/j.expneurol.2013.07.010. Epub 2013 Jul 25.

13.

Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury.

Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, Nagoshi N, Kitamura K, Kumagai G, Nishino M, Tomisato S, Higashi H, Nagai T, Katoh H, Kohda K, Matsuzaki Y, Yuzaki M, Ikeda E, Toyama Y, Nakamura M, Yamanaka S, Okano H.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12704-9. doi: 10.1073/pnas.0910106107. Epub 2010 Jul 6.

14.

Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.

Kawabata S, Takano M, Numasawa-Kuroiwa Y, Itakura G, Kobayashi Y, Nishiyama Y, Sugai K, Nishimura S, Iwai H, Isoda M, Shibata S, Kohyama J, Iwanami A, Toyama Y, Matsumoto M, Nakamura M, Okano H.

Stem Cell Reports. 2016 Jan 12;6(1):1-8. doi: 10.1016/j.stemcr.2015.11.013. Epub 2015 Dec 24.

15.

Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury.

Kumagai G, Okada Y, Yamane J, Nagoshi N, Kitamura K, Mukaino M, Tsuji O, Fujiyoshi K, Katoh H, Okada S, Shibata S, Matsuzaki Y, Toh S, Toyama Y, Nakamura M, Okano H.

PLoS One. 2009 Nov 6;4(11):e7706. doi: 10.1371/journal.pone.0007706.

16.

Transplantation of human neural stem cells for spinal cord injury in primates.

Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S, Yamasaki M, Momoshima S, Ishii H, Ando K, Tanioka Y, Tamaoki N, Nomura T, Toyama Y, Okano H.

J Neurosci Res. 2005 Apr 15;80(2):182-90.

PMID:
15772979
17.

Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice.

Takahashi Y, Tsuji O, Kumagai G, Hara CM, Okano HJ, Miyawaki A, Toyama Y, Okano H, Nakamura M.

Cell Transplant. 2011;20(5):727-39. doi: 10.3727/096368910X536554. Epub 2010 Nov 5.

PMID:
21054930
18.

Neural stem/progenitor cell-laden microfibers promote transplant survival in a mouse transected spinal cord injury model.

Sugai K, Nishimura S, Kato-Negishi M, Onoe H, Iwanaga S, Toyama Y, Matsumoto M, Takeuchi S, Okano H, Nakamura M.

J Neurosci Res. 2015 Dec;93(12):1826-38. doi: 10.1002/jnr.23636. Epub 2015 Aug 24.

PMID:
26301451
19.

Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.

Pomeshchik Y, Puttonen KA, Kidin I, Ruponen M, Lehtonen S, Malm T, Åkesson E, Hovatta O, Koistinaho J.

Cell Transplant. 2015;24(9):1799-812. doi: 10.3727/096368914X684079. Epub 2014 Sep 8.

PMID:
25203632
20.

Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair.

Romanyuk N, Amemori T, Turnovcova K, Prochazka P, Onteniente B, Sykova E, Jendelova P.

Cell Transplant. 2015;24(9):1781-97. doi: 10.3727/096368914X684042. Epub 2014 Aug 19.

PMID:
25259685

Supplemental Content

Support Center